Amphastar Pharmaceuticals (AMPH) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $0.37.
- Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) fell 5256.41% to $0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.26, marking a year-over-year decrease of 2491.69%. This contributed to the annual value of $3.06 for FY2024, which is 1769.23% up from last year.
- According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) is $0.37, which was down 5256.41% from $0.64 recorded in Q2 2025.
- In the past 5 years, Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $0.91 during Q3 2023, and its lowest value of $0.1 during Q1 2021.
- Over the past 5 years, Amphastar Pharmaceuticals' median EPS (Weighted Average and Diluted) value was $0.51 (recorded in 2025), while the average stood at $0.54.
- In the last 5 years, Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) soared by 63750.0% in 2021 and then tumbled by 5256.41% in 2025.
- Quarter analysis of 5 years shows Amphastar Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $0.4 in 2021, then soared by 62.5% to $0.65 in 2022, then grew by 6.15% to $0.69 in 2023, then rose by 7.25% to $0.74 in 2024, then crashed by 50.0% to $0.37 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.37 in Q3 2025, compared to $0.64 in Q2 2025 and $0.51 in Q1 2025.